1 completed, 1 terminated, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow focetria: new trials by email Literature Review of focetria trials Research Report on focetria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| H1N1sw Vaccine in Adult Transplant Recipients Focetria (2x H1N1 vaccine with MF59 adjuvants) - Immunocompromised | Phase 2 | Terminated | HepNet Study House, German Liverfoundation | 13 | 2010-02-01 | 2012-04-16 |
| Vaccination Against Influenza H1N1 in Rheumatic Diseases Focetria (Monovalent MF59-Adjuvanted vaccine) - Influenza, Rheumatic Diseases | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 400 | 2009-11-01 | 2009-11-03 |
| A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine MF59 adjuvanted H1N1 influenza monovalent vaccine, Thymosin alpha 1 - END STAGE RENAL DISEASE | Phase 2 | Completed | sigma-tau i.f.r. S.p.A. | 120 | 2009-11-01 | 2012-03-29 |
Arthritis, Psoriatic (1) · Influenza, Human (1) · Kidney Failure, Chronic (1) · Rheumatic Diseases (1)
HepNet Study House, German Liverfoundation (1) · Tel-Aviv Sourasky Medical Center (1) · sigma-tau i.f.r. S.p.A. (1)
Germany (1) · Italy (1)
Agostino Naso, MD (1) · Michael P Manns, Prof (1)
2009 (1)